.zip file contains: Presentation slides from November 2014 webinar training on adverse events Study handout accompanying training Presentation about expedited reporting on Adverse Events Presentation about reporting via DAERS Case study on Adverse Events Case Study on chest pain
Vincristine sulfate injection is indicated in acute leukemia. Vincristine sulfate injection has also been shown to be useful in combination with other oncolytic agents in Hodgkin’s disease, non–Hodgkin’s malignant lymphomas, rhabdomyosarcoma, neuroblastoma, and Wilms’ tumor.
ZOLINZA is a histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma (CTCL) who have progressive, persistent or recurrent disease on or following two systemic therapies
The following side effects have been associated with use of zidovudine: Decrease in the number of white blood cells that help fight infection Decrease in the number of red blood cells that may cause weakness, dizziness, and fatigue Muscle aches, weakness, and wasting Headache Upset stomach…
RETROVIR is a nucleoside analogue reverse transcriptase inhibitor indicated for:* Treatment of Human Immunodeficiency Virus (HIV-1) infection in combination with other antiretroviral agents. (1.1) * Prevention of maternal-fetal HIV-1 transmission. (1.2)